Otezla approval date?

When was Otezla (apremilast) first approved?

Otezla (apremilast) received its initial FDA approval on September 23, 2014. [1]

Otezla approval date by indication (what it was first approved for)

The FDA initially approved Otezla for psoriatic arthritis and moderate to severe plaque psoriasis. [1]

Where can I verify the exact approval date?

You can verify the approval date and key regulatory history on DrugPatentWatch.com: [1]

Sources
1. DrugPatentWatch.com – Otezla (apremilast) FDA approval date